home / stock / clrb / clrb news

CLRB News and Press, Cellectar Biosciences Inc. From 06/05/20

Stock Information
Company Name: Cellectar Biosciences Inc.
Stock Symbol: CLRB
Market: NASDAQ
Website: cellectar.com
Menu
CLRB CLRB Quote CLRB Short CLRB News CLRB Articles CLRB Message Board
Get CLRB Alerts

News, Short Squeeze, Breakout and More Instantly...
CLRB - Cellectar Biosciences Announces Closing of $20 Million Underwritten Public Offering

FLORHAM PARK, N.J., June 05, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the closing of its previously announced un...
CLRB - APPS, SAVA, PGEN and LPI among midday movers

Gainers: Genius Brands International (NASDAQ: GNUS ) +73% . More news on: Genius Brands International, Inc., Cassava Sciences, Inc., Secoo Holding Limited, Stocks on the move, , Read more ...

CLRB - Cellectar Bio slips 23% after pricing $20M public offering

Cellectar Biosciences (NASDAQ: CLRB ) has priced its public offering for gross proceeds of $20M. More news on: Cellectar Biosciences, Inc., Healthcare stocks news, , Stocks on the move, Read more ...

CLRB - RGA, ARCE among premarket losers

Evofem Biosciences (NASDAQ: EVFM )  -26%  after pricing equity offering. More news on: Evofem Biosciences, Inc., Cellectar Biosciences, Inc., Reinsurance Group of America, Incorporated, Stocks on the move, , Read more ...

CLRB - Cellectar Biosciences Announces Pricing of $20 Million Underwritten Public Offering

FLORHAM PARK, N.J., June 03, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the pricing of an underwritten ...

CLRB - Cellectar Granted SME Status by the European Medicines Agency

FLORHAM PARK, N.J., June 01, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that it has been granted Small ...

CLRB - Healthcare and Tech stocks among premarket losers

La Jolla Pharmaceutical (NASDAQ: LJPC ) -24% . More news on: La Jolla Pharmaceutical Company, Arcus Biosciences, Inc., Mitcham Industries, Inc., Stocks on the move, , Read more ...

CLRB - NVAX, LK among premarket ganers

Mmtec (NASDAQ: MTC ) +168%  on FY results . More news on: Mmtec, Inc., Sky Solar Holdings, Ltd., Cellectar Biosciences, Inc., Stocks on the move, , Read more ...

CLRB - Cellectar Bio's CLR 131 Fast Track'd for lymphatic system cancer

The FDA grants Fast Track status to Cellectar Biosciences (NASDAQ: CLRB ) CLR 131 application for patients with lymphoplasmacytic lymphoma (LPL)/ Waldenstrom’s macroglobulinemia (WM) in patients who have received at least two prior lines of therapy. More news on: Cellectar Biosci...

CLRB - Cellectar Receives FDA Fast Track Designation for CLR 131 in Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia

FLORHAM PARK, N.J., May 26, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the U.S. Food and Drug Administration...
Previous 10 Next 10